KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Capital Expenditures (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Capital Expenditures for 17 consecutive years, with $158.0 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 28.46% to $158.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $527.0 million through Dec 2025, up 24.0% year-over-year, with the annual reading at $527.0 million for FY2025, 24.0% up from the prior year.
  • Capital Expenditures hit $158.0 million in Q4 2025 for Quest Diagnostics, up from $144.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $158.0 million in Q4 2025 to a low of $63.0 million in Q1 2022.
  • Historically, Capital Expenditures has averaged $108.4 million across 5 years, with a median of $105.5 million in 2023.
  • Biggest YoY gain for Capital Expenditures was 101.59% in 2023; the steepest drop was 51.02% in 2023.
  • Year by year, Capital Expenditures stood at $144.0 million in 2021, then grew by 2.08% to $147.0 million in 2022, then crashed by 51.02% to $72.0 million in 2023, then skyrocketed by 70.83% to $123.0 million in 2024, then grew by 28.46% to $158.0 million in 2025.
  • Business Quant data shows Capital Expenditures for DGX at $158.0 million in Q4 2025, $144.0 million in Q3 2025, and $108.0 million in Q2 2025.